Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Statements of Shareholders??? Equity

v3.22.1
Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Ordinary shares
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance at Dec. 31, 2018 $ 1,580 $ 60,905 $ (969) $ (56,096) $ 5,420
Balance (in Shares) at Dec. 31, 2018 3,814,713        
Issuance of ordinary shares and warrants, net of issuance cost $ 763 6,602 7,365
Issuance of ordinary shares and warrants, net of issuance costs (in Shares) 1,800,040        
Classification of warrants from equity to liability, see note 2c (1,804) (1,804)
Classification of warrants from liability to equity, see note 9 - A(2) 3,139 3,139
Conversion of prepaid warrants to ordinary shares $ 22 (22)
Conversion of prepaid warrants to ordinary shares (in Shares) 50,000        
Exercise of options $ 3 4 7
Exercise of options (in Shares) 6,076        
Share-based compensation 1,125 1,125
Share-based compensation (in Shares)        
Net income (loss) for the period (11,164) (11,164)
Balance at Dec. 31, 2019 $ 2,368 69,949 (969) (67,260) 4,088
Balance (in Shares) at Dec. 31, 2019 5,670,829        
Issuance of ordinary shares and warrants, net of issuance cost $ 195 4,205 4,400
Issuance of ordinary shares and warrants, net of issuance costs (in Shares) 445,000        
Shares issued for services $ 6 63     69
Shares issued for services (in Shares) 15,429        
Conversion of prepaid warrants to ordinary shares $ 355 (355)
Conversion of prepaid warrants to ordinary shares (in Shares) 811,085        
Exercise of options $ 9 80 89
Exercise of options (in Shares) 21,495        
Share-based compensation 1,605 1,605
Share-based compensation (in Shares)        
Net income (loss) for the period (5,774) (5,774)
Balance at Dec. 31, 2020 $ 2,933 75,547 (969) (73,034) 4,477
Balance (in Shares) at Dec. 31, 2020 6,963,838        
Issuance of ordinary shares and warrants, net of issuance cost $ 1,035 31,758 32,793
Issuance of ordinary shares and warrants, net of issuance costs (in Shares) 2,250,000        
Exercise of Warrants, net of issuance costs of $51, see note 9 - A(2) $ 665 5,053 5,718
Exercise of Warrants, net of issuance costs of $51, see note 9 - A(2) (in Shares) 1,442,149        
Exercise of options $ 31 268 299
Exercise of options (in Shares) 66,037        
Share-based compensation 1,597 1,597
Share-based compensation (in Shares)        
Net income (loss) for the period 237 237
Balance at Dec. 31, 2021 $ 4,664 $ 114,223 $ (969) $ (72,797) $ 45,121
Balance (in Shares) at Dec. 31, 2021 10,722,024